Chandrakant Lahariya
NationalityIndian
Alma materUniversity of Delhi, University of Geneva, Pasteur Institute, Paris
Years active1998–present
Notable workTill We Win: India's Fight Against The COVID-19 Pandemic, 2020 A Review of Preventive and Social Medicine, 2008

Chandrakant Lahariya is an Indian medical doctor, public health & policy expert and writer.

Lahariya is the author of the book Till We Win: India's Fight Against The COVID-19 Pandemic.

In early 2008, Lahariya joined the World Health Organization in India, where - in the years which followed - he coordinated the organization's work on the new vaccines introduced in the country. [1][2]

Awards and recognitions

In the year 2012, he received Indian Council of Medical Research’s Dr B.C. Srivastava Foundation Award for his work on translating community-based health research into public policy interventions.[3]

In October 2020, in a study conducted by Stanford University and published in the reputed PLoS Biology, Lahariya was listed amongst the top 2% of researchers globally, in the fields of pediatrics and public health.[4] He was, once again, included in the list of Top 2% researcher globally, in 2021.

Books and writing

Lahariya is the author of the book Till We Win: India's Fight Against The COVID-19 Pandemic, co-authored with Randeep Guleria of AIIMS, New Delhi and Gagandeep Kang of Christian Medical College, Vellore.[5]

In 2009-10, Lahariya was the guest editor (along with Dr Vinod Kumar Paul, then Professor of pediatrics at AIIMS, New Delhi and now Member of NITI Aayog, Govt. of India) of a special series on child survival in India.[6][7][8] This series was published in the Indian Journal of Pediatrics and had contributions from leading Indian health experts including Prema Ramachandran, Deoki Nandan, Prasanna K. Hota, and Shiv Lal. Lahariya who had co-authored a few articles, including one with Dr Vinod Kumar Paul of NITI Aayog.[9]

Selected publications

References

  1. ↑ "India's medical experts come together to pen a book titled 'Till We Win: India's Fight Against the Covid-19 Pandemic'". Mumbai Mirror. 24 November 2020.
  2. ↑ Subcommittee on Introduction of Hib Vaccine in Universal Immunization Program, National Technical Advisory Group on Immunization, India (November 2009). "NTAGI subcommittee recommendations on Haemophilus influenzae type B (Hib) vaccine introduction in India" (PDF). Indian Pediatrics. 46 (11): 945–54. PMID 19955578.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  3. ↑ "Awardee Details". ICMR.
  4. ↑ Ioannidis, John P. A.; Boyack, Kevin W.; Baas, Jeroen (16 October 2020). "Updated science-wide author databases of standardized citation indicators". PLOS Biology. 18 (10): e3000918. doi:10.1371/journal.pbio.3000918. PMC 7567353. PMID 33064726.
  5. ↑ "Till We Win".
  6. ↑ Dr. V. K. Paul, Professor
  7. ↑ "Dr. V.K. Paul". AIIMS NEW.
  8. ↑ "The Indian Journal of Pediatrics, Volume 77, Issue 3 - Springer". link.springer.com.
  9. ↑ Lahariya, Chandrakant; Paul, Vinod K. (November 2010). "Burden, Differentials, and Causes of Child Deaths in India". The Indian Journal of Pediatrics. 77 (11): 1312–1321. doi:10.1007/s12098-010-0185-z. PMID 20830536. S2CID 3441068.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.